رفتن به محتوا

تداخل‌های دارویی

Aprepitant + Cobicistat

شدت: شدید

Aprepitant and Cobicistat: major interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Cobicistat is a strong CYP3A inhibitor and can substantially increase aprepitant exposure. This may worsen aprepitant adverse effects. Aprepitant in turn may modestly raise levels of other CYP3A substrates in the regimen.

معنای این تداخل به زبان ساده

Aprepitant and Cobicistat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Aprepitant belongs to Gastrointestinal Tract; Cobicistat belongs to Miscellaneous.

سطح شواهد: Moderate

چرا رخ می‌دهد

Cobicistat strongly inhibits CYP3A4, the main enzyme clearing aprepitant.

اقدام لازم

Avoid the combination where possible, or use the single-dose aprepitant regimen with monitoring for adverse effects. Consider an alternative antiemetic such as a 5-HT3 antagonist with dexamethasone adjusted for CYP3A inhibition.

از داروساز چه بپرسید

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Aprepitant و Cobicistat، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Aprepitant with Cobicistat?

MediHelp rates the interaction as major. Aprepitant and Cobicistat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cobicistat is a strong CYP3A inhibitor and can substantially increase aprepitant exposure. This may worsen aprepitant adverse effects. Aprepitant in turn may modestly raise levels of other CYP3A substrates in the regimen.

How serious is the interaction between Aprepitant and Cobicistat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, or use the single-dose aprepitant regimen with monitoring for adverse effects. Consider an alternative antiemetic such as a 5-HT3 antagonist with dexamethasone adjusted for CYP3A inhibition.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود